New England Professional Planning Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$238K Hold
3,148
0.27% 36
2016
Q1
$204K Sell
3,148
-467
-13% -$29.5K 0.2% 40
2015
Q4
$250K Buy
+3,615
New +$239K 0.28% 34
2015
Q3
Sell
-3,216
Closed -$213K 46
2015
Q2
$213K Buy
+3,216
New +$212K 0.28% 44

Other funds holding BMY

New England Professional Planning Group's BMY Position: Q2 2016 in Review

New England Professional Planning Group held its Bristol-Myers Squibb (BMY) position steady in Q2 2016 at 3,148 shares worth $238K. The position accounts for 0.27% of the portfolio, ranked #36.

New England Professional Planning Group first reported a position in BMY in Q2 2015 and has held it in 4 quarters since. The position peaked at $250K in Q4 2015. 1,576 funds tracked by Wall St. Rank hold BMY as of Q2 2016.

  • New England Professional Planning Group held 3,148 shares of Bristol-Myers Squibb worth $238K as of Q2 2016.
  • New England Professional Planning Group left its Bristol-Myers Squibb share count unchanged in Q2 2016.
  • Bristol-Myers Squibb made up 0.27% of New England Professional Planning Group's portfolio in Q2 2016, its #36 holding.
  • New England Professional Planning Group first reported a position in Bristol-Myers Squibb in Q2 2015 and has held it in 4 quarters since.
  • New England Professional Planning Group's Bristol-Myers Squibb position peaked at $250K in Q4 2015.
  • 1,576 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2016.

Based on New England Professional Planning Group's 13F filing for Q2 2016, filed 28 Jul 2016.